Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck, Pfizer trot out more support for latecomer SGLT2 candidate ertugliflozin
Merck, Pfizer trot out more support for latecomer SGLT2 candidate ertugliflozin
Merck, Pfizer trot out more support for latecomer SGLT2 candidate ertugliflozin
Submitted by
admin
on June 11, 2017 - 9:24am
Source:
Fierce Pharma
News Tags:
Merck
Pfizer
ertugliflozin
diabetes
Headline:
Merck, Pfizer trot out more support for latecomer SGLT2 candidate ertugliflozin
Do Not Allow Advertisers to Use My Personal information
